Skip to Content

Atomo Diagnostics Ltd Ordinary Shares - Stock Quote AT1

Rating as of

Morningstar's Atomo Diagnostics Ltd Ordinary Shares Stock Analysis

Valuation
Currency in AUD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - AT1

Atomo Diagnostics Ltd Ordinary Shares's Company Profile

Business Description

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company develops point of care devices for rapid diagnostic testing. Its device is used to test infectious diseases including COVID-19, viral vs bacterial differentiation and female health. Its offers AtomoRapid RDP Platform with the device including Galileo, Pascal, Newton, Losev, Franklin and Elion. The firm operates in a single segment, being medical device research and development.

Contact
701-703 Parramatta Road, Level 2
Syndey, NSW, 2040, Australia
T +61 290994750
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Jun 30, 2022
Stock Type
Employees